Gut immune system and oral tolerance

British Journal of Nutrition

Volumn 109, Issue SUPPL. 2, 2013, Pages

  Castro Sánchez, Patricia ^a   Martín Villa, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Mucosa associated lymphoid tissue; Mucosal immunity; Oral immunisation; Regulatory T cells

Indexed keywords

AUTOANTIGEN; LATENCY ASSOCIATED PEPTIDE; MONOCLONAL ANTIBODY CD3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNE DISEASE; BYSTANDER EFFECT; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; GASTROINTESTINAL TRACT; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATORY DISEASE; INTESTINE EPITHELIUM CELL; INTESTINE LYMPHATIC TISSUE; INTRAEPITHELIAL LYMPHOCYTE; LAMINA PROPRIA; LYMPHOCYTE; MESENTERY LYMPH NODE; MONONUCLEAR CELL; MUCOSAL IMMUNITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PEYER PATCH; REGULATORY T LYMPHOCYTE;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; LYMPHOID TISSUE; T-LYMPHOCYTES, REGULATORY;

EID: 84873800448     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512005223     Document Type: Article

References (53)

1. McGhee JR, Mestecky J, Dertzbaugh MT, et al. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10, 75-88.
2. Ponda PP & Mayer L (2005) Mucosal epithelium in health and disease. Curr Mol Med 5, 549-556.
3. Baumgart DC & Dignass AU (2002) Intestinal barrier function. Curr Opin Clin Nutr Metab Care 5, 685-694.
4. Moens E & Veldhoen M (2012) Epithelial barrier biology: good fences make good neighbours. Immunology 135, 1-8.
5. Mowat AM, Millington OR & Chirdo FG (2004) Anatomical and cellular basis of immunity and tolerance in the intestine. J Pediatr Gastroenterol Nutr 39, Suppl. 3, S723-S724.
6. Suzuki K, Kawamoto S, Maruya M, et al. (2010) GALT: organization and dynamics leading to IgA synthesis. Adv Immunol 107, 153-185.
7. Mowat AM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3, 331-341.
8. Johansen FE & Kaetzel CS (2011) Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol 4, 598-602.
9. Mowat AM & Bain CC (2011) Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun 3, 550-564.
10. Cheroutre H, Lambolez F & Mucida D (2011) The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11, 445-456.
11. Leon F (2011) Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. J Immunol Methods 363, 177-186.
12. Brandtzaeg P (2009) Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 70, 505-515.
13. Rocha B (2007) The extrathymic T-cell differentiation in the murine gut. Immunol Rev 215, 166-177.
14. Rocha B, Guy-Grand D & Vassalli P (1995) Extrathymic T cell differentiation. Curr Opin Immunol 7, 235-242.
15. Howie D, Spencer J, DeLord D, et al. (1998) Extrathymic T cell differentiation in the human intestine early in life. J Immunol 161, 5862-5872.
16. Pickard JM & Chervonsky AV (2010) Sampling of the intestinal microbiota by epithelial M cells. Curr Gastroenterol Rep 12, 331-339.
17. Yamamoto M, Pascual DW & Kiyono H (2012) M celltargeted mucosal vaccine strategies. Curr Top Microbiol Immunol 354, 39-52.
18. Blumberg RS, Lencer WI, Zhu X, et al. (1999) Antigen presentation by intestinal epithelial cells. Immunol Lett 69, 7-11.
19. Rescigno M (2010) Intestinal dendritic cells. Adv Immunol 107, 109-138.
20. Rescigno M, Urbano M, Valzasina B, et al. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2, 361-367.
21. Gewirtz AT & Madara JL (2001) Periscope, up! Monitoring microbes in the intestine. Nat Immunol 2, 288-290.
22. Pabst R & Rothkotter HJ (2006) Structure and function of the gut mucosal immune system. Adv Exp Med Biol 579, 1-14.
23. Sanz Y & De Palma G (2009) Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function. Int Rev Immunol 28, 397-413.
24. Rodriguez-Juan C, Perez-Blas M, Suarez-Garcia E, et al. (2000) Lens culinaris, Phaseolus vulgaris and vicia faba lectins specifically trigger IL-8 production by the human colon carcinoma cell line CACO-2. Cytokine 12, 1284-1287.
25. Rodriguez-Juan C, Perez-Blas M, Valeri AP, et al. (2001) Cell surface phenotype and cytokine secretion in Caco-2 cell cultures: increased RANTES production and IL-2 transcription upon stimulation with IL-1beta. Tissue Cell 33, 570-579.
26. Martin-Villa JM, Ferre-Lopez S, Lopez-Suarez JC, et al. (1997) Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens 50, 586-592.
27. Abadie V, Sollid LM, Barreiro LB, et al. (2011) Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29, 493-525.
28. Dwinell MB, Johanesen PA & Smith JM (2003) Immunobiology of epithelial chemokines in the intestinal mucosa. Surgery 133, 601-607.
29. Miron N & Cristea V (2012) Enterocytes: active cells in tolerance to food and microbial antigens in the gut. Clin Exp Immunol 167, 405-412.
30. Faria AM & Weiner HL (2006) Oral tolerance and TGF-betaproducing cells. Inflamm Allergy Drug Targets 5, 179-190.
31. Sakaguchi S (2004) Naturally arising CD4\+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22, 531-562.
32. Faria AM & Weiner HL (2006) Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol 13, 143-157.
33. Whiteside TL (2012) Disarming suppressor cells to improve immunotherapy. Cancer Immunol Immunother 61, 283-288.
34. Zhang L, Bertucci AM, Ramsey-Goldman R, et al. (2009) Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8\+ Treg cells are associated with immunological remission of lupus. J Immunol 183, 6346-6358.
35. Chen ML, Yan BS, Kozoriz D, et al. (2009) Novel CD8\+ Treg suppress EAE by TGF-beta-and IFN-gamma-dependent mechanisms. Eur J Immunol 39, 3423-3435.
36. Weiner HL, da Cunha AP, Quintana F, et al. (2011) Oral tolerance. Immunol Rev 241, 241-259.
37. Hyytiainen M, Penttinen C & Keski-Oja J (2004) Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 41, 233-264.
38. Rubtsov YP & Rudensky AY (2007) TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 7, 443-453.
39. Kohm AP, Williams JS, Bickford AL, et al. (2005) Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4\+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis. J Immunol 174, 4525-4534.
40. Oida T & Weiner HL (2011) Murine CD4 T cells produce a new form of TGF-beta as measured by a newly developed TGF-beta bioassay. PLoS One 6, e18365.
41. Li MO, Wan YY & Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 26, 579-591.
42. Nakamura K, Kitani A & Strober W (2001) Cell contactdependent immunosuppression by CD4(\+)CD25(\+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194, 629-644.
43. Oida T & Weiner HL (2010) TGF-beta induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction. PLoS One 5, e15523.
44. Miller A, Lider O & Weiner HL (1991) Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174, 791-798.
45. Zhang J, Markovic-Plese S, Lacet B, et al. (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179, 973-984.
46. Sun JB, Czerkinsky C & Holmgren J (2010) Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol 71, 1-11.
47. Sun JB, Czerkinsky C & Holmgren J (2012) B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(\+) regulatory T cells and protect against experimental autoimmune encephalomyelitis. J Immunol 188, 1686-1697.
48. George-Chandy A, Eriksson K, Lebens M, et al. (2001) Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 69, 5716-5725.
49. Khoury SJ, Hancock WW & Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176, 1355-1364.
50. Slavin AJ, Maron R & Weiner HL (2001) Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol 13, 825-833.
51. Belghith M, Bluestone JA, Barriot S, et al. (2003) TGF-betadependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9, 1202-1208.
52. Ochi H, Abraham M, Ishikawa H, et al. (2008) New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity. J Neurol Sci 274, 9-12.
53. Frenkel D, Huang Z, Maron R, et al. (2005) Neuroprotection by IL-10-producing MOG CD4\+ T cells following ischemic stroke. J Neurol Sci 233, 125-132.